GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OK Biotech Co Ltd (TPE:4155) » Definitions » Scaled Net Operating Assets

OK Biotech Co (TPE:4155) Scaled Net Operating Assets : 0.79 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is OK Biotech Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

OK Biotech Co's operating assets for the quarter that ended in Mar. 2024 was NT$2,851 Mil. OK Biotech Co's operating liabilities for the quarter that ended in Mar. 2024 was NT$423 Mil. OK Biotech Co's Total Assets for the quarter that ended in Dec. 2023 was NT$3,067 Mil. Therefore, OK Biotech Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.79.


OK Biotech Co Scaled Net Operating Assets Historical Data

The historical data trend for OK Biotech Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OK Biotech Co Scaled Net Operating Assets Chart

OK Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.81 0.73 0.71 0.71 0.77

OK Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.79 0.73 0.75 0.73 0.79

Competitive Comparison of OK Biotech Co's Scaled Net Operating Assets

For the Medical Devices subindustry, OK Biotech Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OK Biotech Co's Scaled Net Operating Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OK Biotech Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where OK Biotech Co's Scaled Net Operating Assets falls into.



OK Biotech Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

OK Biotech Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(2702.018-339.289)/3061.194
=0.77

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3067.358 - 365.34
=2702.018

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=672.264 - 94.107 - 238.868
=339.289

OK Biotech Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2024 )
=(Operating Assets (Q: Mar. 2024 )-Operating Liabilities (Q: Mar. 2024 ))/Total Assets (Q: Dec. 2023 )
=(2850.717-422.542)/3067.358
=0.79

where

Operating Assets(Q: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3114.957 - 264.24
=2850.717

Operating Liabilities(Q: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=694.698 - 92.434 - 179.722
=422.542

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OK Biotech Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of OK Biotech Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


OK Biotech Co (TPE:4155) Business Description

Traded in Other Exchanges
N/A
Address
No.91, Gongdao 5th Road, Section 2, Hsinchu, TWN, 30070
OK Biotech Co Ltd is engaged in the manufacturing of electronic materials and medical devices. The products of the company include Portable Nebulizer, Blood Glucose Meter, Glucometer, Blood Sugar Meter, Blood Glucose Test Strips, and others.

OK Biotech Co (TPE:4155) Headlines

No Headlines